IL17A and rheumatoid arthritis: Extending previous studies implicating roles for these pathways in cytokine driven RA pathogenesis [18–22], we now show sustained activation of ERK (predominantly ERK2) and particularly, STAT3 following chronic stimulation with IL-17 or IL-1β (Fig 3C).